This medication is specifically intended for individuals with obesity due to certain genetic conditions, such as POMC, LEPR, or MC4R deficiencies, which can affect the bodys ability to regulate weight
This is not a surface-level overview
Several GLP-1 RAs have additional FDA approval for: Heart protection : Dulaglutide [archived link], liraglutide [archived link], and semaglutide [archived link] have been proven to prevent strokes and heart attacks in people with risk factors, such as diabetes or obesity
While GLP-1 medications are an effective tool for controlling blood sugar levels and supporting weight loss
Because GLP-1 drugs slow gastric emptying, they may affect absorption of oral contraceptives and oral progestins medications commonly used to suppress endometriosis symptoms
For more about Wegovy, type 2 diabetes, and obesity in childhood and adolescence: Teenager Just Diagnosed with Type 2 Diabetes: What Do My Patients Ask